Long- term outcome of thalidomide and cyclosporine in patients with IPSS low/intermediate- 1 myelodysplastic syndromes
Wang, Jingya, Qin, Tiejun, Xu, Zefeng, Zhang, Yue, Zhang, Hongli, Fang, Liwei, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Li, Bing, Xiao, Zhijian
Published in Zhōnghuá xuèyèxué zázhì (01.11.2015)
Published in Zhōnghuá xuèyèxué zázhì (01.11.2015)
Get full text
Journal Article
Clinical efficacy analysis of recombinant human erythropoietin in the treatment of lower-risk myelodysplastic syndromes
Zhang, Hongli, Qin, Tiejun, Xu, Zefeng, Fang, Liwei, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Zhang, Yue, Xiao, Zhijian
Published in Zhōnghuá xuèyèxué zázhì (01.01.2014)
Published in Zhōnghuá xuèyèxué zázhì (01.01.2014)
Get more information
Journal Article
Prognostic evaluation of comorbidities in patients with myelodysplastic syndrome
Li, Yi, Qin, Tiejun, Xu, Zefeng, Zhang, Yue, Fang, Liwei, Zhang, Hongli, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Li, Bing, Xiao, Zhijian
Published in Zhōnghuá xuèyèxué zázhì (01.03.2015)
Published in Zhōnghuá xuèyèxué zázhì (01.03.2015)
Get full text
Journal Article
A study of prognostic value of cytogenetics in patients with primary myelofibrosis
Li, Bing, Xu, Junqing, Xu, Zefeng, Li, Chengwen, Qin, Tiejun, Fang, Liwei, Zhang, Hongli, Hu, Naibo, Pan, Lijuan, Qu, Shiqiang, Wang, Jingya, Zhang, Yue, Zhang, Peihong, Xiao, Zhijian
Published in Zhōnghuá xuèyèxué zázhì (01.11.2014)
Published in Zhōnghuá xuèyèxué zázhì (01.11.2014)
Get more information
Journal Article
Comparison of low-dose thalidomide and prednisone combined with or without danazol for the treatment of primary myelofibrosis-associated anemia
Xu, Junqing, Xu, Zefeng, Qin, Tiejun, Li, Bing, Fang, Liwei, Zhang, Hongli, Hu, Naibo, Pan, Lijuan, Qu, Shiqiang, Zhang, Yue, Xiao, Zhijian
Published in Zhōnghuá xuèyèxué zázhì (01.08.2014)
Published in Zhōnghuá xuèyèxué zázhì (01.08.2014)
Get more information
Journal Article
Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy
Qu, Shiqiang, Yan, Yiru, Li, Chengwen, Xu, Zefeng, Cai, Wenyu, Qin, Tiejun, Zhang, Peihong, Jia, Yujiao, Pan, Lijuan, Gao, Qingyan, Li, Bing, Liu, Jinqin, Jiao, Meng, Xiao, Zhijian
Published in Leukemia research reports (01.01.2023)
Published in Leukemia research reports (01.01.2023)
Get full text
Report